BNET Industries

Market Cap:$29.8M
Last Fiscal Year Sales:$22.9M
  • Public
  • US
Dow Jones Description

Thousands of corporations nationwide rely upon Psychemedics' unique, patented technology for their pre-employment and employee drug testing needs. Our superior technology, along with our reputation for meticulous quality control and customer service, have made Psychemedics the leader in drug testing through hair analysis. Clients range in size from regional employers to Fortune 500 companies with thousands of locations nationwide. Additionally, Psychemedics' patented technology is in use by Federal Reserve Banks and dozens of government and medical research programs. Many schools also use our patented process.

Chairman, President and C.E.O
Raymond C. Kubacki Jr.
Number of Employees 116
Contact Information

125 Nagog Park

Acton, Massachusetts 01720

psychemedics.co...

(978) 206-8220

NAICS Code Medical Laboratories: 621511

Recent Events

  • Psychemedics Corporation Announces Third Quarter Results

    11/03/09 - Financial Announcement - View Story

News & Analysis

psychemedics corp. - All News and Analysis

Decision Makers

Name (plus bio) Position
Peter C. Monson Chief Financial Officer, Vice President and Treasurer
William Thistle Senior Vice President and General. Counsel
Jonathan D Compton Vice President, Marketing
Michael I. Schaffer Vice President of Laboratory Operations
Raymond J Ruddy Vice President, Controller
William Dausey Vice President, Sales
Edward S Brewer Secretary

Board of Directors

Name (plus bio) Position
Raymond C. Kubacki Jr. Chairman, President and C.E.O
Fred J. Weinert Board of Directors
Harry Connick Board of Directors
Walter S Tomeson Jr. Board of Directors
Walter S. Tomenson Jr. Board of Directors

Mr. Kubacki has been the Company s President and Chief Executive Officer and has served as a director of the Company since 1991. On November 30, 2003, he was elected Chairman of the Board. He is a Director of Protection One, Inc. He is also a trustee of the Center for Excellence in Education based in Washington, DC.

Organization Position Status
Psychemedics Corporation Chairman, President and C.E.O Current
Ray Kubacki Board of Directors Current
Protection One, Inc. Board of Directors Current
The Center for Excellence Board of Directors Current
Massachusetts Financial Services Company Investment Officer Former
Harvard College B.A. Former

Organization Position Status
Psychemedics Corporation Chief Financial Officer, Vice President and Treasurer Current

Organization Position Status
Psychemedics Corporation Senior Vice President and General. Counsel Current
Psychemedics Corporation Board of Directors Current
MGM Grand Associate General Counsel Former

Organization Position Status
Psychemedics Corporation Vice President, Marketing Current

Dr. Schaffer joined the Company in 1999 as Vice President of Laboratory Operations. Prior to joining the Company, he served as Director of Toxicology, Technical Manager and Responsible Person for the Leesburg, Florida laboratory of SmithKline Beecham Clinical Laboratories, from 1990 to 1999. Dr. Schaffer has been an inspector for the Substance Abuse and Mental Health Services Administration s National Laboratory Certification Program since 1989. Dr. Schaffer was also a member of the Board of Directors of the American Board of Forensic Toxicologists from 1990 to 1999.

Organization Position Status
Psychemedics Corporation Vice President of Laboratory Operations Current
Psychemedics Corporation Board of Directors Current

Organization Position Status
Psychemedics Corporation Vice President, Controller Current
Concord Communications, Inc. Director of Finance and Investor Relations Former

Organization Position Status
Psychemedics Corporation Vice President, Sales Current

Organization Position Status
Psychemedics Corporation Secretary Current

Mr. Weinert is an entrepreneur whose current business activities are concentrated in real estate development, theatre and film development. He is the Chief Executive Officer and Chairman of Bella Media Plc. He also serves as the Chief Executive Officer of Bella Cinema LLC, Barrington Services Group, Inc., and San Telmo, Inc. He has served on the Business Advisory Council for the University of Dayton for over 20 years. Mr. Weinert has been a director of the Company since 1991. The information required by Item 405 of Regulation S-K will be set forth in the Proxy Statement of the Company relating to the 2006 Annual Meeting of Stockholders to be held on May 10, 2007 and is incorporated herein by reference. We have a code of ethics that applies to all of our employees and non-employee directors. This code satisfies the requirements set forth in Item 406 of Regulation S-K and applies to all relevant persons set forth therein. The Company will mail to interested parties a copy of the Code of Ethics upon written request and without charge. Such request shall be made to our General Counsel, 125 Nagog Park, Acton, Massachusetts 01720.

Organization Position Status
Psychemedics Corporation Board of Directors Current

Mr. Connick was District Attorney for Orleans Parish (New Orleans, LA) from 1974 to 2003, having been elected five times. Mr. Connick has also been a national leader in the war on drugs. His national leadership was prominent in advocating drug testing to help high school students remain drug-free and establishing model programs in a number of schools. In December 2002, Mr. Connick received from Drug Czar John P. Walters the Director s Award for Distinguished Service in recognition of exemplary accomplishment and distinguished service in the fight against illegal drugs. Mr. Connick has been a director of the Company since 2003.

Organization Position Status
Psychemedics Corporation Board of Directors Current

Organization Position Status
Psychemedics Corporation Board of Directors Current

Organization Position Status
Psychemedics Corporation Board of Directors Current
Finpro, Inc. Chairman Former

Executive News

  • Psychemedics Corporation Announces Sales & Marketing Agreement With Bupa in UK

    Reuters - 5/19/09 - View Story

  • Psychemedics Corporation Announces Sales & Marketing Agreement With Bupa in UK

    Forbes.com - 5/19/09 - View Story

  • Psychemedics Corporation Announces Sales & Marketing Agreement With Bupa in UK

    PR Newswire via Yahoo! - 5/19/09 - View Story

advertisement
     PMD $5.75 +0.09 (1.59% )
Average Volume 12,826
Shares Outstanding 5.20M
Market Cap 29.9M
Year High 15
Year Low 3.032
Earnings Per Share 0.23
P/E Ratio 25.00
Dividend 0.48
Yield 8.35
advertisement